Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10

Health-related outcomes and economic burden in Japan: focus on inflammatory bowel disease, multiple sclerosis, and depression

Authors Yamabe K

Received 17 August 2018

Accepted for publication 18 September 2018

Published 23 October 2018 Volume 2018:10 Pages 653—654


Checked for plagiarism Yes

Editor who approved publication: Professor Giorgio Lorenzo Colombo

Kaoru Yamabe

Healthcare Policy and Access, Takeda Pharmaceutical Company Limited, Chuou-ku, Tokyo, Japan

This series presents articles using data collected from the National Health and Wellness Survey1 in Japan to assess the burden of inflammatory bowel disease (IBD), multiple sclerosis (MS), and depression using a common methodology involving cases vs. controls and patient-reported outcome measures (PROMs).  


Kaoru Yamabe is an employee of Takeda Pharmaceutical Company Limited, which funded this research. The author reports no other conflict of interest in this work.



Kantar Health. National Health and Wellness Survey. Patient-Reported Healthcare Insights. New York: Kantar Health. Available from: Accessed July 25, 2018.

Dove Medical Press encourages responsible, free and frank academic debate. The content of the ClinicoEconomics and Outcomes Research ‘Editorial’ section does not necessarily represent the views of Dove Medical Press, its officers, agents, employees, related entities or the ClinicoEconomics and Outcomes Research editors. While all reasonable steps have been taken to confirm the content of each Editorial, Dove Medical Press accepts no liability in respect of the content of any Editorial, nor is it responsible for the content and accuracy of any Editorial.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.